Atracurium Besylate Injection
Company: FauldingApproval Status: Approved April 1997
Treatment for: muscle relaxant
Areas: Musculoskeletal
General Information
Preserved and unpreserved forms of Atracurium Besylate Injection, an intermediate duration muscle relaxant, have been approved for marketing. The drugs are the generic equivalents of Tracrium, an adjunct to general anesthesia during surgery or mechanical ventilation that is marketed by GlaxoWellcome.
Atracurium Besylate Injection Drug Information
The Atracurium Besylate Injection drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
